Document Detail


Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy.
MedLine Citation:
PMID:  21308385     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The identification of predictive factors of NAbs development might have a relevant impact on clinical practice. Our objective is to look after predictive factors of NAbs development in MS IFN Beta-1b-treated patients. Database was screened for patients on IFN Beta-1b treatment with an Expanded Disability Status Scale (EDSS) at a baseline between 1 and 3.5, disease duration shorter than 15 years, and NAbs analysis performed every 6 months. The NAbs positive status was analysed in relation to baseline clinical, neuropsychological and brain imaging measures. Forty-nine patients were included. Sixteen patients had become NAbs positive at some point on IFN therapy (35%). NAbs producers differed from not producers for higher incidence of cognitive deficit and higher lesion load (OR = 5.0 and 5.6, respectively). Our study suggests that NAbs development might be a marker of a more aggressive disease and that worse outcome in NAbs producers might be biased by baseline condition.
Authors:
R Lanzillo; G Orefice; A Prinster; G Ventrella; R Liuzzi; V Scarano; C Florio; G Vacca; A Brunetti; B Alfano; V Brescia Morra; V Bonavita
Related Documents :
11360065 - Power spectrum analysis and conventional electromyogram in duchenne muscular dystrophy.
693775 - The myofascial pain dysfunction: dental symptoms and psychological and muscular functio...
19284615 - Identification of subtelomeric genomic imbalances and breakpoint mapping with quantitat...
16873935 - Muscle coenzyme q10 concentrations in patients with probable and definite diagnosis of ...
9629845 - Temporal ictal electroencephalographic frequency correlates with hippocampal atrophy an...
4066085 - Acute and exacerbated chronic respiratory tract infections: treatment with a combinatio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-10
Journal Detail:
Title:  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology     Volume:  -     ISSN:  1590-3478     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100959175     Medline TA:  Neurol Sci     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Neurological Sciences, Federico II University, Via Pansini 5, Naples, Italy, robertalanzillo@libero.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autotrophic, sulfur-oxidizing actinobacteria in acidic environments.
Next Document:  Prevalence of pilus-encoding islets and clonality of pneumococcal isolates from children with acute ...